Oct. 20, 2026 — Johnson & Johnson has announced the U.S. launch of its Shockwave C2 Aero Fly Coronary IVL catheter designed to treat a broad range of calcified coronary artery lesions in half the time ...
Oct. 20, 2026 — Penumbra, Inc. recently announced that the U.S. Food and Drug Administration (FDA) has granted clearance ...
With a sirolimus-based drug-coated balloon (DCBs) entering the U.S. market, interventional cardiologists treating in ...
Oct.19, 2026 – Jupiter Endovascular has announced publication of full results from its SPIRARE II pivotal trial ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
Oct. 20, 2026 — Johnson & Johnson has announced the U.S. launch of its Shockwave C2 Aero Fly Coronary IVL catheter ...
Oct. 14, 2026 — GLP-1 weight loss drugs known may help protect against heart failure even at doses too low to produce ...
Oct. 14, 2026 — W. L. Gore & Associates' medical business has announced U.S. Food and Drug Administration approval of an ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
Medical device portfolios now move on two very different clocks. New technologies can gain clinical adoption within ...
Oct. 12, 2026 — Endovascular Engineering (E2) has announced that the U.S. Food and Drug Administration (FDA) has granted ...
Oct. 12, 2026 — The American Heart Association has expanded its education portfolio to help clinicians put the new ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Oct. 12, 2026 — Siemens Healthineers announced it ultrasound business plans to concentrate its efforts on cardiovascular ...
Oct. 6, 2026 — Penumbra, Inc. has announced results from a subset analysis of the landmark STORM-PE randomized ...
Oct. 8, 2026 – At the Heart Failure Society of America (HFSA) Annual Scientific Meeting in Phoenix, Arizona, Bayer ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Oct. 8, 2026 — Government officials, global health leaders, clinicians, patient advocates, professional societies and ...
Oct. 6, 2026 — Riverain Technologies has announced that its FDA-cleared ClearRead Chest suite will be available through ...
Oct. 7, 2026 — Boston Scientific Corp. has appointed Joseph M. Fitzgerald to executive vice president and chief ...
October 22, 2026
